ADC Therapeutics SA
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES AND USES THEREOF

Last updated: 20 Apr 2022

Abstract:

The present disclosure relates to novel pyrrolobenzodiazepine antibody-drug conjugates (PBD-ADCs) and therapeutic uses thereof.

Status:

Application

Type:

Utility

Filling date:

22 Sep 2021

Issue date:

31 Mar 2022

Full patent description

Patent application document